Trials / Sponsors / Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors. Solid Tumors | Phase 1 / Phase 2 | 2025-05-01 |
| Not Yet Recruiting | A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome POEMS Syndrome | Phase 1 | 2024-08-31 |
| Unknown | A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2024-01-11 |
| Unknown | Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors Neoplasms, Neoplasms by Histologic Type | Phase 1 | 2022-12-28 |